Identification of Candidate Biomarkers and Cancer Genes AHNAK2 and EPPK1 in Pancreatic Cancer

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 18, Issue 8

Abstract

Aims: The lack of specific symptoms at early tumor stages, together with a high biological aggressiveness of the tumor contribute to the high mortality rate for pancreatic cancer (PC). Improved screening for earlier diagnosis, through the detection of diagnostic and prognostic biomarkers provides the best hope of increasing the rate of curatively resectable carcinomas. The aim of this study is to provide new targets for use as biomarkers in PC. Study Design: In a previous study, we identified novel candidate cancer genes and biomarkers that were significantly upregulated in PC, through a meta-analysis of large number of microarray datasets, using bioinformatics methods. In this study, we analyzed the expression of these genes in a panel of pancreatic cancer cell lines by quantitative Reverse Transcription-PCR (qRT-PCR). Place and Duration of Study: Department of Chemistry and Biochemistry and Department of Biology, University of Northern Iowa, USA, between June 2014 and Dec 2015. Methodology: We analyzed the expression of three genes, AHNAK2, EPPK1 and IGHG3 in a panel of seven standard PC cell lines, AsPC-1, BxPC-3, Capan-2, CFPAC-1, HPAF-II, PANC-1, and SW 1990 by Relative Quantification. qRT-PCR experiments were conducted in triplicate, and each experiment was replicated twice using different passages. Results: AHNAK2 was significantly upregulated in all PC cell lines tested, with P values < 0.005 except for PANC-1 (P < 0.05). EPPK1 too was significantly upregulated (P < 0.05) in six of seven PC cell lines tested. While IGHG3 was nominally upregulated in all PC cell lines, upregulation was significant (P < 0.05) in only four PC cell lines. Conclusion: Our results confirm that AHNAK2 and EPPK1 are novel candidates for use as biomarkers in pancreatic cancer. IGHG3 does not appear to be a suitable candidate, due to its low levels of expression in both PC and control cell lines.

Authors and Affiliations

Alex Smith, Logan Poole, Kavita Dhanwada, Nalin C. W. Goonesekere

Keywords

Related Articles

Antibiotic Use, Cost, and Consumption in Tertiary Hospitals in Lebanon: A Comparative Study Before and After an Implementation of Antibiotic-Restriction Program (ARP)

Aims: To compare the antibiotic use, cost, and consumption before and after an implementation of an antibiotic-restriction program (ARP) in governmental hospitals setting in Lebanon. Study Design: A retrospective cohort...

Poor Cardiovascular Risk Profile Following a Vegan Diet: A Case Report

Introduction: Vegetarianism and veganism are becoming increasingly popular in North America due to reasons ranging from environmental motives to animal rights. While the vegetarian lifestyle allows some egg and dairy ite...

Caudal Block for Digital-guided Transrectal Prostate Biopsy

Objective: To assess the effectiveness and safety of caudal block on the pain associated with digital guided transrectal Tru-Cut biopsy of the prostate. Subjects and Methods: Over a two year period, from July 2013 to Jun...

Association between Socio-Demographic Factors and the Type of Tobacco Consumption among Subjects Attending a Rural Hospital, South India

Aim: To assess the association between socio-demographic factors and type of tobacco consumption among subjects attending a rural hospital in south India. Methods: A pre-tested questionnaire was designed for recording t...

Effect of Group Cognitive Behavioural Therapy with Compassion Training on Depression: A Study Protocol

Aims: Cognitive behavioural therapy (CBT) is one of the evidence-based treatments for depression. However, some patients high in self-criticism do not respond to CBT. Compassion-focused therapy (CFT) is featured in treat...

Download PDF file
  • EP ID EP341084
  • DOI 10.9734/BJMMR/2016/28034
  • Views 49
  • Downloads 0

How To Cite

Alex Smith, Logan Poole, Kavita Dhanwada, Nalin C. W. Goonesekere (2016). Identification of Candidate Biomarkers and Cancer Genes AHNAK2 and EPPK1 in Pancreatic Cancer. Journal of Advances in Medicine and Medical Research, 18(8), 1-8. https://europub.co.uk/articles/-A-341084